{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:20:16Z","timestamp":1790508016655,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10157-019-01696-8","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T05:45:23Z","timestamp":1549345523000},"page":"676-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study"],"prefix":"10.1007","volume":"23","author":[{"given":"Malik","family":"Aydin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kurylowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Ganschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lentze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"1696_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","volume":"98","author":"International Study of Kidney Disease in Children\/ISKDC","year":"1981","unstructured":"International Study of Kidney Disease in Children\/ISKDC. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr. 1981;98:561\u20134.","journal-title":"J Pediatr"},{"key":"1696_CR2","first-page":"1267","volume-title":"Pediatric kidney disease","author":"MA Nash","year":"1992","unstructured":"Nash MA, Edelmann CM Jr, Bernstein J, Barnett HL. Minimal change nephrotic syndrome, diffuse mesangial hypercellularity and focal glomerulosclerosis. In: Edelmann CM Jr, editor. Pediatric kidney disease. 2nd ed. Boston: Little, Brown; 1992. pp.\u00a01267\u201390.","edition":"2"},{"key":"1696_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2369-14-25","volume":"14","author":"N Hussain","year":"2013","unstructured":"Hussain N, Zello JA, Vasilevska-Ritovska J, Banh TM, Patel VP, Patel P, et al. The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome. BMC Nephrology. 2013;14:25. https:\/\/doi.org\/10.1186\/1471-2369-14-25 .","journal-title":"BMC Nephrology"},{"issue":"1","key":"1696_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10157-017-1433-6","volume":"22","author":"I Franke","year":"2018","unstructured":"Franke I, Aydin M, Llamas Lopez CE, Kurylowicz L, Ganschow R, et al. The incidence of the nephrotic syndrome in childhood in Germany. Clin Exp Nephrol. 2018;22(1):126\u201332. https:\/\/doi.org\/10.1007\/s10157-017-1433-6 .","journal-title":"Clin Exp Nephrol"},{"key":"1696_CR5","first-page":"13","volume":"122","author":"A Bagga","year":"2005","unstructured":"Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13\u201328.","journal-title":"Indian J Med Res"},{"key":"1696_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0022-3476(82)80692-6","volume":"101","author":"International Study of Kidney Disease in Children\/ISKDC","year":"1982","unstructured":"International Study of Kidney Disease in Children\/ISKDC. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr. 1982;101:514\u20138.","journal-title":"J Pediatr"},{"key":"1696_CR7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769\u201376.","journal-title":"J Am Soc Nephrol"},{"key":"1696_CR8","first-page":"493","volume-title":"Oxford textbook of clinical nephrology","author":"M Broyer","year":"1998","unstructured":"Broyer M, Meyrier A, Niaudet P, Habib R. Minimal changes and focal segmental glomerular sclerosis. In: Davison AM, editor. Oxford textbook of clinical nephrology. 2nd ed. Vol.\u00a01. Oxford: Oxford university Press; 1998. pp.\u00a0493\u2013535.","edition":"2"},{"key":"1696_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00467-005-2097-0","volume":"21","author":"DS Gipson","year":"2006","unstructured":"Gipson DS, Chin H, Presler TP, et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21:344\u20139.","journal-title":"Pediatr Nephrol"},{"key":"1696_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0022-3476(72)80291-9","volume":"81","author":"NJ Siegel","year":"1972","unstructured":"Siegel NJ, Goldberg B, Krassner LS, Hayslett JP. Long-term follow-up of children with steroid-responsive nephrotic syndrome. J Pediatr. 1972;81:251\u20138.","journal-title":"J Pediatr"},{"key":"1696_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Gr\u00fcnfeld JP, Niaudet P. Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003;41:550\u20137.","journal-title":"Am J Kidney Dis"},{"key":"1696_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","volume":"147","author":"EM R\u00fcth","year":"2005","unstructured":"R\u00fcth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005;147:202\u20137.","journal-title":"J Pediatr"},{"key":"1696_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","volume":"1","author":"RS Trompeter","year":"1985","unstructured":"Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS. Long-term outcome for children with minimal-change nephrotic syndrome. Lancet. 1985;1:368\u201370.","journal-title":"Lancet"},{"key":"1696_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(89)91266-X","volume":"1","author":"MA Lewis","year":"1989","unstructured":"Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ. Nephrotic syndrome: From toddlers to twenties. Lancet. 1989;1:255\u20139.","journal-title":"Lancet"},{"key":"1696_CR15","first-page":"548","volume":"54","author":"MW Schwartz","year":"1974","unstructured":"Schwartz MW, Schwartz GJ, Cornfeld D. A 16 year follow up study of 163 children with nephrotic syndrome. Pediatrics. 1974;54:548\u201352.","journal-title":"Pediatrics"},{"key":"1696_CR16","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1046\/j.1523-1755.1998.00121.x","volume":"54","author":"N Zidar","year":"1998","unstructured":"Zidar N, Cavic MA, Kenda RB, Ferluga D. Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation. Kidney Int. 1998;54:1320\u20133.","journal-title":"Kidney Int"},{"key":"1696_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0272-6386(05)80005-8","volume":"37","author":"JN Sheu","year":"2001","unstructured":"Sheu JN, Jeun-Horng C. Minimal Change Nephrotic Syndrome in Children with Intrauterine Growth Retardation. Am J Kidney Dis. 2001;37:909\u201314.","journal-title":"Am J Kidney Dis"},{"key":"1696_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/bmj.301.6746.259","volume":"301","author":"DJP Barker","year":"1990","unstructured":"Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ. 1990;301:259\u201362.","journal-title":"BMJ"},{"key":"1696_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0140-6736(89)90710-1","volume":"2","author":"DJP Barker","year":"1989","unstructured":"Barker DJP, Winter PD, Osmond C, Simmons SJ. Weight in infancy and death from ischemic heart disease. Lancet. 1989;2:577\u201380.","journal-title":"Lancet"},{"key":"1696_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/bmj.303.6809.1019","volume":"303","author":"CN Hales","year":"1991","unstructured":"Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019\u201322.","journal-title":"BMJ"},{"key":"1696_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1471-0528.1992.tb13726.x","volume":"99","author":"SA Hinchliffe","year":"1992","unstructured":"Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol. 1992;99:296\u2013301.","journal-title":"Br J Obstet Gynaecol"},{"key":"1696_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1046\/j.1523-1755.2003.00018.x","volume":"63","author":"M Hughson","year":"2003","unstructured":"Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003;63:2113\u201322.","journal-title":"Kidney Int"},{"key":"1696_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1046\/j.1523-1755.2000.00225.x","volume":"58","author":"R Manalich","year":"2000","unstructured":"Manalich R, Reyes L, Herrera M, Melendi C, Fundora I. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int. 2000;58:770\u20133.","journal-title":"Kidney Int"},{"key":"1696_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000046275","volume":"21","author":"H Matsukura","year":"2001","unstructured":"Matsukura H, Inaba S, Shinozaki K, Yanagihara T, Hara M, Higuchi A, Takada T, Tanizawa T, Miyawaki T. Influence of prolonged corticosteroid therapy on the outcome of steroid-responsive nephrotic syndrome. Am J Nephrol. 2001;21:362\u20137.","journal-title":"Am J Nephrol"},{"key":"1696_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1442-200X.2007.02429.x","volume":"49","author":"O Motoyama","year":"2007","unstructured":"Motoyama O, Iitaka K. Final height in children with steroid-sensitive nephrotic syndrome. Pediatrics Int. 2007;49:623\u20135.","journal-title":"Pediatrics Int"},{"key":"1696_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/adc.57.7.544","volume":"57","author":"O Koskimies","year":"1982","unstructured":"Koskimies O, Vilska J, Rapola J, Hallmann N. Long-term outcome of primary nephrotic syndrome. Arch Dis Child. 1982;57:544\u20138.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1696_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1700993","volume":"378","author":"R Calderon-Margalit","year":"2018","unstructured":"Calderon-Margalit R, Golan E, Twig G, Leiba A, Tzur D, Afek A, et al. History of childhood kidney disease and risk of adult end-stage renal disease. N Engl J Med. 2018;378(5):428\u201338.","journal-title":"N Engl J Med"},{"key":"1696_CR28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJMoa040367","volume":"351","author":"MB Leonard","year":"2004","unstructured":"Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid sensitive nephrotic syndrome. N Engl J Med. 2004;351:868\u201375.","journal-title":"N Engl J Med"},{"key":"1696_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00467-004-1694-7","volume":"20","author":"FL Weng","year":"2005","unstructured":"Weng FL, Shults J, Herskovitz RM, Zemel BS, Leonard MB. Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol. 2005;20:56\u201363.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1696_CR30","doi-asserted-by":"publisher","first-page":"e0167159","DOI":"10.1371\/journal.pone.0167159","volume":"11","author":"J Truthmann","year":"2016","unstructured":"Truthmann J, Mensink GBM, Bosy-Westphal A, Scheidt-Nave C, Schienkiewitz A. Metabolic Health in Relation to Body Size: Changes in Prevalence over Time between 1997-99 and 2008-11 in Germany. PLoS One. 2016;11(11):e0167159.","journal-title":"PLoS One"},{"issue":"1","key":"1696_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018;14(1):57\u201370. https:\/\/doi.org\/10.1038\/nrneph.2017.155 .","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1696_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4274\/jcrpe.1867","volume":"7","author":"S Elmao\u011fullar\u0131","year":"2015","unstructured":"Elmao\u011fullar\u0131 S, Tepe D, U\u00e7akt\u00fcrk SA, Karaca Kara F, Demirel F. Prevalence of dyslipidemia and associated factors in obese children and adolescents. J Clin Res Pediatr Endocrinol. 2015;7(3):228\u201334.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"5","key":"1696_CR33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/VHRM.S2928","volume":"4","author":"U Korsten-Reck","year":"2008","unstructured":"Korsten-Reck U, Kromeyer-Hauschild K, Korsten K, Baumstark MW, Dickhuth HH, Berg A. Frequency of secondary dyslipidemia in obese children. Vasc Health Risk Manag. 2008;4(5):1089\u201394.","journal-title":"Vasc Health Risk Manag"},{"key":"1696_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0009-9120(03)00103-6","volume":"36","author":"A M\u00e9rouani","year":"2003","unstructured":"M\u00e9rouani A, L\u00e9vy E, Mongeau J-J, Robitaille P, Lambert M, Delvin EE. Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem. 2003;36:571\u20134.","journal-title":"Clin Biochem"},{"key":"1696_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00467-008-1029-1","volume":"24","author":"MH Kniazewska","year":"2009","unstructured":"Kniazewska MH, Obuchowics AK, Wielkoszy\u0144ski T, Zmudzi\u0144ska-Kitczak J, Urban K, Marek M, Witanowska J, Siero\u0144-Sto\u0142tny K. Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol. 2009;24:549\u201354.","journal-title":"Pediatr Nephrol"},{"key":"1696_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00467-003-1176-3","volume":"18","author":"F Emma","year":"2003","unstructured":"Emma F, Sesto A, Rizzoni G. Long-term linear growth of children with severe steroid responsive nephrotic syndrome. Pediatr Nephrol. 2003;18:783\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1696_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0140-6736(85)90851-7","volume":"2","author":"KD Foote","year":"1985","unstructured":"Foote KD, Brocklebank JT, Meadow SR. Height attainment in children with steroid responsive nephrotic syndrome. Lancet. 1985;2:917\u20139.","journal-title":"Lancet"},{"key":"1696_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00467-006-0100-z","volume":"21","author":"BJ Foster","year":"2006","unstructured":"Foster BJ, Shults J, Zemel BS, Leonard MB. Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2006;21:973\u201380.","journal-title":"Pediatr Nephrol"},{"key":"1696_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1651-2227.2007.00154.x","volume":"96","author":"ME Salsano","year":"2007","unstructured":"Salsano ME, Graziano L, Luongo I, Pilla P, Giordano M, Lama G. Atopy in childhood idiopathic nephrotic syndrome. Acta paediatrica. 2007;96:561\u20136.","journal-title":"Acta paediatrica"},{"key":"1696_CR40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/adc.56.7.517","volume":"56","author":"SR Meadow","year":"1981","unstructured":"Meadow SR, Sarsfield JK, Scott DG, Rajah SM. Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child. 1981;56:517\u201324.","journal-title":"Arch Dis Child"},{"key":"1696_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000185873","volume":"54","author":"JF Hu","year":"1990","unstructured":"Hu JF, Liu YZ. Elevated serum IgE levels in children with nephrotic syndrome, a steroid-resistant sign? Nephron. 1990;54:275.","journal-title":"Nephron"},{"issue":"5","key":"1696_CR42","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.ajkd.2009.03.019","volume":"54","author":"M Abdel-Havez","year":"2009","unstructured":"Abdel-Havez M, Shimada M, Lee PY, Johnson RJ, Garin EH. Idiopathic nephrotic syndrome and atopy. Is there a common link? Am J Kidney Dis. 2009;54(5):945\u201353.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1696_CR43","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3109\/08820538.2016.1154178","volume":"31","author":"K Mundy","year":"2016","unstructured":"Mundy K, Nichols E, Lindsey J. Socioeconomic disparities in cataract prevalence, characteristics, and management. Semin Ophthalmol. 2016;31(4):358\u201363.","journal-title":"Semin Ophthalmol"},{"key":"1696_CR44","first-page":"30","volume":"53","author":"JT Brocklebank","year":"1982","unstructured":"Brocklebank JT, Harcourt RB, Meadow SR. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. Arch Dis Childhood. 1982;53:30\u20134.","journal-title":"Arch Dis Childhood"},{"key":"1696_CR45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF00869818","volume":"4","author":"R Bogdanovic","year":"1990","unstructured":"Bogdanovic R, Banicevic M, Cvoric A. Testicular function following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study. Pediatr Nephrol. 1990;4:451\u20134.","journal-title":"Pediatr Nephrol"},{"key":"1696_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0022-3476(80)80035-7","volume":"97","author":"L Callis","year":"1980","unstructured":"Callis L, Nieto J, Vila A, Rende J. Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr. 1980;97:653\u20136.","journal-title":"J Pediatr"},{"key":"1696_CR47","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0022-3476(78)80031-6","volume":"92","author":"P Guesry","year":"1978","unstructured":"Guesry P, Lenoir G, Broyer M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr. 1978;92:299\u2013303.","journal-title":"J Pediatr"},{"key":"1696_CR48","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0022-3476(74)80758-4","volume":"84","author":"J Penso","year":"1974","unstructured":"Penso J, Lippe B, Ehrlich R, Smith FG. Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome. J Pediatr. 1974;84:831\u20136.","journal-title":"J Pediatr"},{"key":"1696_CR49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(73)90491-1","volume":"1","author":"J Rapola","year":"1973","unstructured":"Rapola J, Koskimies O, Huttunen NP, Floman P, Vilska J, Hallmann N. Cyclophoshamide and the pubertal testis. Lancet. 1973;1:98\u20139.","journal-title":"Lancet"},{"issue":"1","key":"1696_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10157-016-1266-8","volume":"21","author":"B Basu","year":"2017","unstructured":"Basu B, Babu BG, Mahapatra TK. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic syndrome. Clin Exp Nephrol. 2017;21(1):143\u201351.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-019-01696-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01696-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T11:29:52Z","timestamp":1662895792000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-019-01696-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s10157-019-01696-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that they have no competing interests. This work has not been published before and it is not under consideration for publication anywhere else. Its publication has been approved by all co-authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All retrospectively and prospectively analyzed data involving human participants were in accordance with the ethical standards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval was obtained by the Ethics Committee of the Faculty of Medicine, Rheinische Friedrich-Wilhelms-University, Bonn, Germany, and the study was assigned the human study registration number 081\/05. The data extraction and analyses were performed pseudonymously; an additional participant informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}